Request 1

Please supply me with your most up to date wound care formulary (please indicate if you do not work from a formulary)?

Response 1

Available on the Rotherham CCG website: 

http://www.rotherhamccg.nhs.uk/Downloads/Top%20Tips%20and%20Therapeutic%20Guidelines/Therapeutic%20guidelines/Wound%20Care%20formulary%20guide.pdf

Request 2

Who has operational responsibility for the formulary including the addition or deletion of products? 

Response 2

There is a wound care group comprising of RCCGs Medicines Management Team (MMT) members and Tissue Viability Nurses (TVNs) that assess new products.

Request 3

Please provide information on how compliance with your formulary is enforced? 

Response 3

Via an electronic audit tool. 

Request 4

Please provide information on how products are evaluated prior to being accepted onto the formulary? If this is part of a clinical evaluation or clinical trial, please provide the results. 

Response 4

Review of evidence base. 

Request 5

Please provide information on who is responsible for the cost of wound care in your setting – is it CCG or Acute? 

Response 5

The CCG holds the budget but the purchase and supply of wound care products is managed jointly by the CCG’s MMT and TVNs who are employed by the acute trust.

Request 6

Please provide information if the wound care products are on prescription FP10?

Response 6

It is not clear what information you would like, therefore, if you would clarify your request we will be happy to respond again. 

Request 7

Please provide a list of the wound care products that you are planning to keep on prescription FP10?

Response 7

None. 

Request 8

Please provide information if you are planning to take wound care products off prescription FP10? 

Response 8

All wound care products are supplied via direct purchase contract awarded after a full public sector procurement exercise. 

Request 9

Please provide a list of the wound care products that you are planning to take off prescription FP10? 

Response 9

All wound care products are off-prescription. 

Request 10

Do you hold information about your patient demographic? If so, please provide information on what is your patient demographic and what are the most commonly treated wounds from your patient demographic 

Response 10

RCCG does not hold this information. 

Request 11

Please provide any information that you have relating to the average monthly usage of each product in the formulary? 

Response 11

RCCG does not hold this information. 

Request 12

Please provide information on the number of wound care products used that are not currently on the formulary? 

Response 12

All products in the drug tariff that are not in the formulary are non-formulary. All non-formulary products are used only after authorisation by a Tissue Viability Nurse. We do not hold a record of these patient specific requests.

Request 13

Please provide any information on the monthly usage levels for non-formulary wound care products in the last twelve months?

Response 13

RCCG does not hold this information. 

Request 14

How often do you review your wound care formulary and when was this last undertaken? 

Response 14

The wound care formulary is constantly under review. 

Request 15

Please provide information about the procedure that you use of the information you assess when reviewing your formulary? 

Response 15

The evidence base supporting a product is considered. If the evidence base is robust an evaluation of the product is undertaken.